학술논문
Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case–control study
Document Type
Article
Author
Chatzilena, A.; Challen, R.; Danon, L.; Hyams, C.; Marlow, R.; Adegbite, D.; Kinney, J.; Clout, M.; Oliver, J.; Finn, A.; Maskell, N.; King, J.; Morley, A.; Langdon, A.; Turner, A.; Mattocks, A.; Osborne, B.; Grimes, C.; Mitchell, C.; Bridgeman, E.; Scott, E.; Perkins, F.; Bayley, F.; Ruffino, G.; Valentine, G.; Tilzey, G.; Kellett Wright, J.; Brzezinska, J.; Cloake, J.; Milutinovic, K.; Helliker, K.; Maughan, K.; Fox, K.; Minou, K.; Ward, L.; Fleming, L.; Morrison, L.; Smart, L.; Wright, L.; Grimwood, L.; Bellavia, M.; Vasquez, M.; Garcia Gonzalez, M.; Jeenes-Flanagan, M.; Chang, N.; Grace, N.; Manning, N.; Griffiths, O.; Croxford, P.; Sequenza, P.; Lazarus, R.; Walters, R.; Heath, R.; Antico, R.; Nammuni Arachchge, S.; Suppiah, S.; Mona, T.; Riaz, T.; Mackay, V.; Maseko, Z.; Taylor, Z.; Friedrich, Z.; Szasz-Benczur, Z.
Source
In: The Lancet Regional Health - Europe . (The Lancet Regional Health - Europe, February 2023, 25)
Subject
Language
English
ISSN
26667762